Publicaciones en colaboración con investigadores/as de Hospital Infanta Leonor (14)

2022

  1. Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: The Spanish COVID-19 KRT Registry

    Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1685-1697

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2021

  1. COVID-19 vaccination among Spanish nephrologists: Acceptance and side effects

    Journal of Healthcare Quality Research, Vol. 36, Núm. 6, pp. 363-369

  2. Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines

    Nefrologia, Vol. 41, Núm. 4, pp. 412-416

  3. Suboptimal personal protective equipment and SARS-CoV-2 infection in Nephrologists: a Spanish national survey

    Clinical Kidney Journal, Vol. 14, Núm. 4, pp. 1216-1221

  4. The impact of age on mortality in chronic haemodialysis popu-lation with covid-19

    Journal of Clinical Medicine, Vol. 10, Núm. 14

2020

  1. Is vitamin-D supplementation not useful in patients at risk of fractures and falls?

    Gynecological Endocrinology, Vol. 36, Núm. 2, pp. 93-95

2019

  1. Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients

    Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106

  2. The Big Data Sjögren consortium: A project for a new data science era

    Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23

  3. The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment

    Endocrine, Vol. 64, Núm. 3, pp. 441-455

2018

  1. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project)

    Clinical and Experimental Rheumatology, Vol. 36, pp. S102-S111

  2. Severe, life-threatening phenotype of primary Sjögren's syndrome: Clinical characterisation and outcomes in 1580 patients (the GEAS-SS Registry)

    Clinical and Experimental Rheumatology, Vol. 36, pp. S121-S129

2016

  1. Systemic activity and mortality in primary Sjögren syndrome: Predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 2, pp. 348-355

2014

  1. Systemic involvement in primary Sjögren's syndrome evaluated by the EULAR-SS disease activity index: Analysis of 921 spanish patients (GEAS-SS registry)

    Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 321-331